Abstract
Aim: In this study, we focused on the p53 codon 72 polymorphism and HPV infections as a possible contributing factor in susceptibility to prostate cancer (PCa). Methods: Eighty histopathologically confirmed prostate biopsies comprising of 40 cancer cases and 40 benign prostate hyperplasia cases were used. Results: A significant difference was not observed between HPV presence and PCa progression. Our results showed that the p53 protein with Arg (p53-Arg72) variant contributes to the development of PCa. Conclusion: There is a near-significant association between Arg/Arg polymorphism and PCa.
Financial & competing interests disclosure
We express our thanks to our colleagues in Virology Department, School of Public Health, Tehran University of Medical Sciences. This study was supported by Tehran University of Medical Sciences, Grant No. 27005. The authors have no other relevant affiliations or financialinvolvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.
Ethical conduct of research
The study was approved by the medical ethics committee from Tehran University of Medical Sciences (No. 139401220). In addition, for investigations involving human subjects, informed consent has been obtained from the participants involved.